Dr. Marc Andrew Cohen, MD

Dr. Cohen practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Cohen's NPI, 1073679098, was assigned on December 28, 2006. Dr. Cohen graduated from Perelman School of Medicine - Philadelphia in 2005. Dr. Cohen holds New York license 260819.

Dr. Cohen's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Cohen's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center (MSK), Department of Surgery. Dmand AI also links Dr. Cohen to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cohen practices. Vendor and product names are available with a free account.

Otolaryngology is Dr. Cohen's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Cohen is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Cohen's licenses on file in 3 states: New York, New Jersey and Pennsylvania.

Dmand AI lists endoscopic sinus surgery and thyroid surgery among the conditions Dr. Cohen treats.

CMS data shows 248 Medicare services from Dr. Cohen across 8 procedure codes in 2024, for 181 Medicare patients. Medicare paid $19,508 for them.

CMS counts 181 Medicare patients who saw Dr. Cohen in 2024. The largest group is 65 to 74, with 88 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cohen's median patient age at 69, with 54% women.

In 2019, Dr. Cohen wrote 14 Medicare Part D claims. They cover 1 drug, with $224 in total drug cost. In 2018, CMS named 15 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Cohen for performance year 2024, reported as part of a group. Dr. Cohen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cohen as offering telehealth.

Dmand AI links 54 papers to Dr. Cohen, published from 2015 to 2025. 2022 was the busiest year, with 12. The most frequent topics are Carcinoma, Squamous Cell, Paranasal Sinus Neoplasms and Head and Neck Neoplasms. Dr. Cohen has published most often in Oral Oncol. Dr. Cohen's most frequent co-authors are Ian Ganly, MD, PhD, Jennifer Rose Cracchiolo, MD and Richard J. Wong, MD.

Dmand AI links Dr. Cohen to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Cushing Syndrome and Pituitary ACTH Hypersecretion.

CMS Open Payments shows 24 general payments to Dr. Cohen from 10 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abiomed paid the most, $592.

Dr. Cohen graduated from Perelman School of Medicine - Philadelphia in 2005.

Dr. Cohen is in network with 15 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.